Sign in

David Sancho

@sancholab.bsky.social
1K followers 327 following 127 posts

Passionate about #immunology. Sensing damaged self, infections & microbiota by DCs and macrophages to ignite innate & adaptive immunity. #Immunometabolism Professor of Immunology @CNIC, Madrid, Spain. www.cnic.es/en/investigacion/immuno…

PostsRepliesMedia
David Sancho @sancholab.bsky.social · 29/09/2026
Are you interested in #cancer #immunotherapy? Do you have experience with mouse or human DCs? Do you want to join us in a challenging project in Madrid to find new DC checkpoints? Apply for the position with us! www.cnic.es/nextcloud/s/... 📆Deadline: 31st October
040
Reposted by David Sancho
caixaresearch.bsky.social @caixaresearch.bsky.social · 24/09/2026
4/ 📰 @sancholab.bsky.social y su equipo (CNIC) han hallado un “punto de control” mitocondrial que permite a las células dendríticas activar los linfocitos T frente a tumores. Un avance que podría mejorar la inmunoterapia contra el cáncer. ✍️ Science Immunology: tinyurl.com/azb8wkja
131
Reposted by David Sancho
caixaresearch.bsky.social @caixaresearch.bsky.social · 20/06/2026
Un estudio liderado por el investigador de nuestra red @sancholab.bsky.social (CNIC) publicado en Science Immunology identifica un “checkpoint” mitocondrial que regula la activación de células dendríticas y su capacidad para activar linfocitos T contra virus y tumores.
tinyurl.com
Science Immunology: Mitochondria control immune cell activation and the effectiveness of immunotherapy
032
Reposted by David Sancho
The French DC Society - Club Francophone des DC (CFCD) @frenchdcsociety.bsky.social · 08/06/2026
Fresh from science immunology, the @sancholab.bsky.social group identifies " the mitochondrial redox metabolism as a key regulator of antigen cross-presentation in conventional type 1 DCs" 👏 and 👇 www.science.org/doi/10.1126/...
science.org
Mitochondrial complex I activity promotes antigen cross-presentation in dendritic cells
Mitochondrial complex I dysfunction in dendritic cells disrupts NAD+/NADH redox balance and impairs antigen cross-presentation.
161
Reposted by David Sancho
The French DC Society - Club Francophone des DC (CFCD) @frenchdcsociety.bsky.social · 03/06/2026
Congrats to the @sancholab.bsky.social et al, for this nice paper in @natcomms.nature.com showing that "type 1 conventional dendritic cell-based vaccination excels at immune memory induction and prevention of cancer recurrence" www.nature.com/articles/s41...
nature.com
Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse - Nature Communications
Dendritic cells (DCs) induce infection-protective immune memory, which has yet to be exploited for cancer therapy. Here we show that type 1 DC vaccines quantitatively and qualitatively favors anti-tum...
161
David Sancho @sancholab.bsky.social · 29/05/2026
How does oxygen sensing shape #alveolar #macrophage (AM) identity? Our new @cp-cellreports.bsky.social: HIF-1α and HIF-2α play distinct, non-redundant roles in AM maturation & function A #metabolic split that defines macrophage biology in the lung. 🔗 doi.org/10.1016/j.ce... #CNIC #immunosky
192
Reposted by David Sancho
Waggoner Lab @labwaggoner.bsky.social · 28/05/2026
HIF-1α and HIF-2α differentially regulate alveolar macrophage maturation and function @cp-cellreports.bsky.social www.cell.com/cell-reports... @sancholab.bsky.social
062
David Sancho @sancholab.bsky.social · 25/05/2026
Does mitochondrial respiration in DCs just “fuel” activation? In our new @ScienceImmunology study, we show that #mitochondrial Complex I is a selective checkpoint for #antigen #cross-presentation in #DCs, especially #cDC1s www.science.org/doi/10.1126/... At: CNIC_CARDIO @inmunosky
1206
Reposted by David Sancho
Waggoner Lab @labwaggoner.bsky.social · 22/05/2026
Mitochondrial complex I dysfunction in dendritic cells disrupts NAD+/NADH redox balance and impairs antigen cross-presentation @sciimmunology.bsky.social @sancholab.bsky.social www.science.org/doi/10.1126/...
073
Reposted by David Sancho
Esteban Ballestar @eballestar.bsky.social · 18/04/2026
Wonderful work, David! The concept that ETC flux—not ATP—licenses cDC1 immunogenicity through /metabolite control of DNA methylation is conceptually beautiful. Congrats to Ignacio, Stefanie and the whole team! Thanks for giving us the chance to learn throught this collaboration!
131
David Sancho @sancholab.bsky.social · 18/04/2026
🤔Do you think that OXPHOS in DCs = tolerance? In our new @cp-cellmetabolism.bsky.social #cnic_cardio & @irbbarcelona.org, we show that active #mitochondrial ETC primes cDC1s for immunogenicity, not tolerance. Life (& #immunometabolism) is not simple ⚡️ OPEN: www.cell.com/cell-metabol... #immunoSky
1228
Reposted by David Sancho
Samarth Hegde @samhegde.bsky.social · 26/02/2026
Always a mind-blowing talk from @sancholab.bsky.social who showed, alongside cool data on macs, that cIII inhibition in cDC1 has functional consequence on anti-tumor immunity > mitochondrial ETC disruption impact on histone demethylase and alter PU.1 pioneer activity. Everything linked !
211
Reposted by David Sancho
Ivan Zanoni @lozanzi.bsky.social · 14/02/2026
#WeekendRead! #InterferonPower! Dunphy @sancholab.bsky.social &co show @cp-immunity.bsky.social that in #macrophages, STING leads to type I #IFNs & ISG15-dependent ISGlatyion of mitochondrial proteins, increasing efferocytosis & driving epigenetic remodeling thus supporting inflammation resolution!
sciencedirect.com
A type I interferon-mitochondrial axis regulates efferocytosis and interferon-stimulated gene induction in macrophages
Macrophage metabolism is intricately linked to cellular function. Contrasting with Toll-like receptor (TLR) stimulation, cytosolic nucleic acid sensin…
1153
David Sancho @sancholab.bsky.social · 14/02/2026
#PhD in #immunometabolism on fatty acid oxidation in #macrophage function. MSCA-DN: unimedizin-mainz.de/unlimited-ms... For our DC8 position apply in parallel in 2 sites: 1. unimedizin-mainz.de/unlimited-ms... 2. cnic.es/en/convocato... (DC8: NOT resident in Spain >12m in last 3 years) #immunosky
040
David Sancho @sancholab.bsky.social · 14/02/2026
Great opportunity for a #PhD on how lipid #metabolism regulates immune cell function in diseases such as cancer and autoimmunity. Train in immunology, bioIT, & metabolism. Apply in parallel in: 1. UNLIMITED: www.unimedizin-mainz.de/unlimited-ms... 2. Local partner site that you choose. #immunosky
The UNLIMITED consortium consists of the following partners:
•	University Medical Center of Mainz, Germany (Positions #3, #6, #15)
•	Carlos III National Cardiovascular Research Centre, Spain (Positions #8)
•	Technical University of Braunschweig, Germany (Positions #9)
•	Leiden University Medical Centre, Netherlands (Position #12)
•	Amsterdam Umc Foundation, Netherlands (Position #2)
•	University of Milan, Italy (Position #7)
•	University of Padua, Italy (Positions #4)
•	The Provost, Fellows, Foundation Scholars & The Other Members of Board, of The College of The Holy & Undivided Trinity, Ireland (Position #11)
•	National Centre for Scientific Research CNRS, France (Position #1)
•	University of Cologne, Germany (Position #13)
•	Luxembourg Institute of Health, Luxembourg (Position #14)
•	Medical University of Vienna, Austria (Position #10)
•	Vugene UAB, Lithuania (Position #5)

Visit https://www.unimedizin-mainz.de/unlimited-msca/consortium.html for all the information and application.
Applications must be done in parallel to local positions of each partner that you choose.Available Positions and Research Topics
The UNLIMITED network offers 15 Doctoral Candidate positions across four themes: 
(1)	development of innovative tools for single-cell and spatial analysis of lipid immunometabolism (Subprojects 1–5); 
(2)	molecular pathways linking lipid metabolism to immune activation and differentiation (Subprojects 6–10); 
(3)	tissue-specific and systemic metabolic regulation of immune function (Subprojects 11–13); 
(4)	discovery of therapeutic targets within lipid metabolism (Subprojects 14–15). 
Collectively, the UNLIMITED network will unravel the lipid–immune interface to generate mechanistic insights that guide the development of precision immunotherapy. Each researcher will receive interdisciplinary, intersectoral training across academia and industry, integrating advanced technologies with transferable and entrepreneurial skills.
153
David Sancho @sancholab.bsky.social · 14/02/2026
Excessive #inflammation? We uncover @cp-immunity.bsky.social that #IFN-I via #ISG15 in macrophages lowers #mitochondrial membrane potential, boosts #efferocytosis, and self limits #ISG amplification: a built in brake that promotes resolution. Open-access: www.cell.com/immunity/ful... #immunosky
194
Reposted by David Sancho
Waggoner Lab @labwaggoner.bsky.social · 28/01/2026
A type I IFN-mitochondrial axis regulates efferocytosis and interferon-stimulated gene induction in macrophages @cp-immunity.bsky.social @sancholab.bsky.social www.cell.com/immunity/ful...
052
David Sancho @sancholab.bsky.social · 21/01/2026
Don't miss the 2nd Conference of the European ImmunoMetabolism Network - EIMN2026 📅10-12th June 2026 📌Luxembourg immunometnet.eu @immunometeurope.bsky.social linkedin.comevents/2ndconferenc...
032
Reposted by David Sancho
caixaresearch.bsky.social @caixaresearch.bsky.social · 12/12/2025
7/ 🔬 What researcher @sancholab.bsky.social (CNIC) sees as an advance to improve cardiovascular health, artist and #laCaixaFoundFellows @guillermomora.bsky.social sees as a moving map. 🎨 They explain it to us in this #SnapshotsOfTheMonth. 👇 bit.ly/3XMZfOc
141
Reposted by David Sancho
RyanLab_TCD @ryanlab.bsky.social · 11/12/2025
I had the pleasure of acting as an external PhD examiner for @aitorjarit.bsky.social in the lab of @sancholab.bsky.social 🇪🇸 during the summer. Today I received his PhD thesis and a beautiful gift of a mitochondria illustrated in the style of an Andalusian tile. Thank you very much!
0131
Reposted by David Sancho
Miguel Soares @elmiguelche.bsky.social · 19/11/2025
🧵 Thrilled to share our new work in @embojournal! Over a century after Metchnikoff recognized macrophages as central to organismal homeostasis, we reveal how they act as metabolic guardians through an unexpected mechanism. www.embopress.org/doi/full/10.... (1/9)
embopress.org
Homeostatic control of energy metabolism by monocyte-derived macrophages | The EMBO Journal
imageimageMacrophages play critical roles in the homeostatic control systems that maintain vital parameters within physiological ranges. This study characterizes how mouse monocyte-derived macrophages...
1186
Reposted by David Sancho
Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) @iib.uam.es · 08/11/2025
🌞 Day 2 begins at La Cristalera! Today we welcome 2 Invited Plenary Speakers: 🔶 Prof. David Sancho, @sancholab.bsky.social (CNIC) 🔶 Prof. Susana Guerrero Salazar (University of Málaga) ✨Another full day of science, ideas, and inspiring talks ahead! #RetreatIIBM_2025 #IIBmCSICUAM @csic.es @uam.es
121
David Sancho @sancholab.bsky.social · 25/07/2025
Gracias @caixaresearch.bsky.social por el sólido apoyo a nuestra investigación. Este reporte es sobre las cDC1s en la generación de respuesta adaptativa en #atherosclerosis & #immunotherapy en el hilo www.ahajournals.org/doi/10.1161/... También apoyo fundamental en: www.nature.com/articles/s41...
share.google
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy | Circulation Research
BACKGROUND: Atherosclerosis is characterized by immune cell accumulation in the arterial wall and adaptive CD4+ T helper 1 immunity contributes to atherosclerosis development. However, how conventiona...
061
Reposted by David Sancho
Samir Giri @isamirgiri.bsky.social · 23/07/2025
This work identifies 'imidazole propionate' as a causal microbial metabolite that promotes atherosclerosis and shows that modulating its levels can potentially prevent cardiovascular disease risk, a promising therapeutic strategy.👇
072
David Sancho @sancholab.bsky.social · 19/07/2025
A gut microbiota metabolite linked to atherosclerosis could revolutionise diagnosis and treatment|ERC erc.europa.eu/news-events/...
erc.europa.eu
A gut microbiota metabolite linked to atherosclerosis could revolutionise diagnosis and treatment
A new study led by the Spanish National Centre for Cardiovascular Research (CNIC) and funded by the European Reasearch Council (ERC) has identified imidazole propionate (ImP), a metabolite produced by...
0237
David Sancho @sancholab.bsky.social · 17/07/2025
Fantástico resumen por @manuelansede.bsky.social 🙏 @caixaresearch.bsky.social por financiar proyecto con 1 millón € 🙏 @ageinves.bsky.social por Severo Ochoa que inició el proyecto + 100K€ a nuestro lab 🙏 @erc.europa.eu ERC-CoG ERC-POC #CNIC_CARDIO Open acess: www.nature.com/articles/s41...
nature.com
Imidazole propionate is a driver and therapeutic target in atherosclerosis - Nature
Imidazole propionate produced by gut microbiota is associated with atherosclerosis in mouse models and in humans, and causes the development of atherosclerosis through activation of the imidazoline-1 ...
172
Reposted by David Sancho
Manuel Ansede @manuelansede.bsky.social · 16/07/2025
Revolución en la medicina: una molécula producida por bacterias del intestino causa la aterosclerosis, culpable de millones de muertes. El descubrimiento, del @sancholab.bsky.social, se acaba de publicar en la revista @nature.com 👇 elpais.com/salud-y-bien...
elpais.com
Revolución en la medicina: una molécula producida por bacterias del intestino causa la aterosclerosis, culpable de millones de muertes
El descubrimiento, gracias a un experimento con cientos de trabajadores del Banco Santander en Madrid, abre la puerta a nuevos tratamientos más allá de reducir el colesterol
16325
Reposted by David Sancho
caixaresearch.bsky.social @caixaresearch.bsky.social · 17/07/2025
Esta investigación del CNIC revela que un metabolito de la microbiota intestinal favorece la aterosclerosis. Descubre más de la mano de uno de los investigadores del equipo 👇🧬
043
David Sancho @sancholab.bsky.social · 16/07/2025
💥 A gut microbe metabolite that drives #atherosclerosis? Yes—Imidazole propionate (ImP) triggers vascular inflammation without changing cholesterol. 🧪 We show the pathway—and how to block it. nature.com/articles/s41... #OpenAccess at @Nature @CNIC_CARDIO #CVD #immunosky #cardiosky #microbiomesky
nature.com
Imidazole propionate is a driver and therapeutic target in atherosclerosis - Nature
Imidazole propionate produced by gut microbiota is associated with atherosclerosis in mouse models and in humans, and causes the development of atherosclerosis through activation of the imidazoline-1 ...
44517
Reposted by David Sancho
Annalaura Mastrangelo @annalaura-m.bsky.social · 16/07/2025
Thank you to my co-author @iroblesv.bsky.social and @sancholab.bsky.social for believing in this project and to all the researchers who contributed to this work!!
022
David Sancho @sancholab.bsky.social · 01/07/2025
Congrats @iannaconelab.bsky.social & team on a wonderful work @natimmunol.nature.com on the immune regulation in the liver: CD4+ T cells license Kupffer cells to rescue CD8+ T cells through IL12 & mainly IL27. Highly relevant for liver immunotherapy!!! 👏🏻👏🏻👏🏻👏🏻👏🏻 #immunosky 👇🏻👇🏻👇🏻
060
David Sancho @sancholab.bsky.social · 22/06/2025
🧬 New immunotherapy for atherosclerosis @ahajournals.bsky.social #CircRes Type 1 dendritic cells (cDC1s) promote atherogenic immunity & can be targeted with tolerogenic nanoparticles. 🔗 doi.org/10.1161/CIRC... #Immunotherapy #Atherosclerosis #Nanomedicine #CNIC_CARDIO #immunosky #cardiosky
183
David Sancho @sancholab.bsky.social · 17/06/2025
Congrats Irene Adán-Barrientos: great thesis presentation & defense at CNIC & @uam.es Thx thesis commitee: Julián Aragonés, Arantxa Cruz-Adalia & Bart Everts on wonderful discussion and visit! Thx Gillian Dunphy @gilliandunphy.bsky.social on fantastic co-supervision!!!
051
Reposted by David Sancho
IRB Barcelona @irbbarcelona.org · 29/04/2025
A type of immune system cell boosts #immunotherapy and prevents #cancer relapse in animal models. ✍️ @ignaciohm.bsky.social @swculek.bsky.social @sancholab.bsky.social et al. 📰 @naturecomms.bsky.social  ➡️ shorturl.at/DaPr3 📌DOI: 10.1038/s41467-025-58289-1. PMID: 40204706 🧪
063
Reposted by David Sancho
gilliandunphy.bsky.social @gilliandunphy.bsky.social · 06/06/2025
This week the world gained another Doctor of Immunology, and we are all the richer for it! Congratulations Dr. Irene on a great thesis and defense. Thank you to the examiners for the interesting discusion and to @sancholab.bsky.social for cosupervising with me these years - it has been a pleasure!
031
Reposted by David Sancho
ACIR @acir-org.bsky.social · 28/04/2025
Heras-Murillo et al. treated mice with tumor cell lysate-loaded syngeneic splenic selected cDC populations. bit.ly/4cKkXJp  @sancholab.bsky.social
021
Reposted by David Sancho
Annalaura Mastrangelo @annalaura-m.bsky.social · 23/04/2025
Great talk by @sancholab.bsky.social shedding light on the role of #dendriticcells in #atherosclerosis: players in shaping immune responses within plaques. #ImmunoAthero
021
David Sancho @sancholab.bsky.social · 15/04/2025
Put a dendritic cell (DC) in your tumor #immunotherapy! cDC1-based vaccines induce strong effector & memory anti-tumor T cell response. Improved immune memory prevents tumor relapse! #CNIC @ageinves.bsky.social @contracancerinv.bsky.social www.nature.com/articles/s41... #immunosky #cancersky (1/7)
nature.com
Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse - Nature Communications
Dendritic cells (DCs) induce infection-protective immune memory, which has yet to be exploited for cancer therapy. Here we show that type 1 DC vaccines quantitatively and qualitatively favors anti-tum...
2113
Reposted by David Sancho
Waggoner Lab @labwaggoner.bsky.social · 10/04/2025
Immunotherapy with cDC1 induces immune memory and limits tumor relapse @naturecomms.bsky.social @sancholab.bsky.social @swculek.bsky.social www.nature.com/articles/s41...
0104
Reposted by David Sancho
The French DC Society - Club Francophone des DC (CFCD) @frenchdcsociety.bsky.social · 10/04/2025
Kudos to @sancholab.bsky.social and @swculek.bsky.social for this work in @naturecomms.bsky.social showing that "that cDC1-based vaccination excels at immune memory induction and prevention of cancer recurrence" www.nature.com/articles/s41...
nature.com
Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse - Nature Communications
Dendritic cells (DCs) induce infection-protective immune memory, which has yet to be exploited for cancer therapy. Here we show that type 1 DC vaccines quantitatively and qualitatively favors anti-tum...
256
Reposted by David Sancho
gilliandunphy.bsky.social @gilliandunphy.bsky.social · 24/03/2025
And it gives me the chance the highlight the best CD4+ T cell/ice cream crossover review: doi.org/10.1038/s415...
doi.org
A fresh look at the T helper subset dogma - Nature Immunology
Single-cell-sequencing techniques enable the decades-old T helper subset dogma to be re-examined in an unsupervised manner, bringing nuance to the definition of known subsets while simultaneously iden...
041
Reposted by David Sancho
Silvestre Roig Lab @silvestreroiglab.bsky.social · 29/03/2025
Stanley Huang told us about metabolic regulation of macrophages and Roser Vento gave us a great talk on spatial analysis of macrophages in reproductive tissues! What an amazing end of session. #EPW2025 #immunosky
031
Reposted by David Sancho
Jose M. Adrover @adrover.bsky.social · 30/03/2025
I had a wonderful time! Great conference and speakers! Thanks @casanova-acebes.bsky.social @sancholab.bsky.social and Carlos Silvestre for the great work organizing such an amazing meeting!
193
Reposted by David Sancho
Casanova-Acebes Lab @casanova-acebes.bsky.social · 28/03/2025
#ElodieSegura investigating cellular and molecular changes of in monocytes upon AhR signaling at #EPW2025
011
Reposted by David Sancho
Mass Lab @masslab.bsky.social · 27/03/2025
Kati Mauel from our lab talking about splenic #macrophages and their response to #malaria infection at #EPW2025 🤩
081
Reposted by David Sancho
Casanova-Acebes Lab @casanova-acebes.bsky.social · 26/03/2025
#teamOrganizers at #EPW2025
031
Reposted by David Sancho
Sofia de Oliveira, Ph.D. @sdeoliveira.bsky.social · 29/03/2025
🧪🔬And Joaquin Canton Sandoval brings home a Best Poster Award from the #EPW2025 YAY🤗🥳 #proudmentor 🤧 #zebrafish
031
Reposted by David Sancho
Silvestre Roig Lab @silvestreroiglab.bsky.social · 27/03/2025
We start the 3rd session of the #EPW2025 on Phagocytes in Motion! With the one and only Sussan Nourshargh! #immunosky
011
Reposted by David Sancho
Silvestre Roig Lab @silvestreroiglab.bsky.social · 28/03/2025
Time matters in Lung Cancer! And neutrophils (of course) are the main suspects! Great talk by Alba de Juan @casanova-acebes.bsky.social lab. #EPW2025 #immunosky
042
Reposted by David Sancho
Silvestre Roig Lab @silvestreroiglab.bsky.social · 28/03/2025
Last flash talk by Lucia de Prado Rivas on mTorc1 in macrophages and atherosclerosis. #EPW2025 #immunosky
011